AdvaMed 2014 · The MedTech Conference

The voices shaping tomorrow's medtech

CEOs, surgeons, regulators, and patient advocates on one stage. Meet the 200+ leaders driving the next era of medical device innovation — from bench to bedside, from compliance to commercialization.

View Full Program Reserve Your Seat
200+Speakers
40Sessions
12Tracks
3Days
Featured Keynote

Opening Day, Main Stage

A frank conversation about how the next decade of medtech will be measured not in patents filed, but in patients reached.

Opening Keynote · Mon, Oct 6 · 9:00 AM

Dr. Eleanor M. Whitfield

President & CEO, Halcyon Surgical Systems · Former Commissioner, U.S. Food & Drug Administration

"We have built a regulatory and engineering culture that can land a device on a beating heart. The next chapter is making sure every patient on Main Street — not just those on the research corridor — benefits from it."

Followed by panel: "Reimbursement, Real-World Evidence, and the Patient Bottom Line"
The Lineup

Speakers by track

Filter the program by topic. Each speaker is confirmed as of the latest program update. Bios are published in the printed delegate guide on-site.

Dr. Jonathan Kim

Chief Medical Officer

Verily Health Technologies

Leads clinical strategy for continuous glucose monitoring in non-insulin-dependent populations. Co-authored 60+ peer-reviewed studies on sensor accuracy and patient-reported outcomes.

Digital Health Clinical Trials Wearables

María Rodríguez, MD

Director, Office of Compliance & Quality

U.S. Food & Drug Administration · CDRH

Twenty years spanning premarket review and post-market surveillance. Frequent advisor to international regulators on EU MDR transition and IMDRF cybersecurity guidance.

Regulatory Quality Systems Cybersecurity

David Tanaka

Founding Partner

Crescent Bay Medventures

Former interventional cardiologist turned investor. Backed twelve medtech exits totaling $4.2B, including three IPOs in structural heart and neuromodulation.

Investors & M&A Cardiovascular IPO Strategy

Dr. Sofia Okafor

Vice President, Health Economics

Edwards Lifesciences

Designs payer engagement models for transcatheter heart valves across CMS, NHS, and private European systems. Frequent co-author with ISPOR workgroups.

Reimbursement Health Economics Cardiovascular

Dr. Raj Patel

Orthopedic Surgeon & Clinical Lead

Hospital for Special Surgery · New York

Pioneer in robotic-assisted knee arthroplasty. Principal investigator on the multi-center Mako vs. manual TKA registry tracking 8,400+ patients since 2018.

Orthopedics Robotics Surgeon Workflow

Aisha Lindgren

Patient Advocate & Research Liaison

National Patient Advocate Foundation

Type 1 diabetic and insulin pump user since age 11. Sits on three FDA patient engagement advisory committees. Speaks on access, affordability, and design inclusion.

Patient Voice Access Digital Health

Henrik Mortensen

CTO & Co-Founder

Nordic Neurostim · Copenhagen

Engineer behind a closed-loop deep brain stimulator for refractory epilepsy. Twenty-one patents, two IDEs cleared in 2023, and a CE mark under the new MDR.

Neuromodulation Closed-Loop R&D

Caroline Beaumont

SVP, Global Regulatory Affairs

Medtronic · Diabetes Operating Unit

Leads a 140-person regulatory team spanning 50 markets. Architect of the company's transition to EU MDR, including 38 legacy device re-certifications.

Regulatory EU MDR Global Strategy
Session Hosts

Our panel moderators

Beyond the keynote, twelve working sessions run in parallel. Each is steered by a moderator with deep operational credibility in the track they lead.

Ethan Goldberg

Managing Director, Medical Devices

Lazard Healthcare Group

Advises on 30+ medtech transactions annually, with a focus on structural heart, surgical robotics, and AI-enabled diagnostics.

M&A Capital Markets